✦ LIBER ✦

PCN31 COST EFFECTIVENESS MODEL OF IV BISPHOSPHONATES IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES: A GERMAN INPATIENT PERSPECTIVE

✍ Scribed by M Botteman; J Hay; JM Stephens; V Barghout; K Quednau

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost effectiveness of bisphosphonates in

✍ M. Botteman; V. Barghout; J. Stephens; J. Hayl; K. Quednau 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 35 KB

423 POSTER A markov model to evaluate th

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Zoledronic acid for the prevention of bo

✍ R Coleman; J Gralow; R Bell; A Lipton 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 356 KB

P104 Continuing benefit of zoledronic ac

✍ M. Zheng; L. Rosen; D. Gordon; M. Kaminski; A. Howell; A. Belch; J. Apffelstaedt 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

P109 Continuing benefit of zoledronic ac

✍ N. Kohno; K. Aogi; H. Minami; S. Nakamura; T. Asaga; Y. Iinos; T. Watanabe; C. G 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 298 KB

PCN71 A COMPARISON OF THE COST-EFFECTIVE

✍ M Botteman; J Carter; S Kaura 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB